Posts by:
Hyntelo has again been recognized as a Sample Vendor in the Gartner “Hype Cycle for Life Science Commercial Operations, 2023” report. For the first time, Hyntelo is recognized as a Sample Vendor in “Modular Atomic Content in LS”, and for the second year as a Sample Vendor in “Advanced Decision Support for Sales”.
[Rome, 12 July 2023] Hyntelo is delighted to announce the appointment of Gianfranco Giannella as Vice Chairman and Board Member. With over 30 years of professional experience in tech-led industry transformation, Giannella brings a wealth of expertise and strategic vision to the company.
Generative AI is no longer a futuristic concept—it’s here, and it's reshaping how Pharma and Life Sciences operate. At the center of this transformation is ChatGPT, the advanced language model by OpenAI that's redefining content creation, communication, and innovation.
Hyntelo is proud to announce that it has been ranked among the 1.000 Europe’s fastest-growing companies in 2023 by Financial Times and Statista, for the third year in a row. A big achievement that confirms and recognizes the company’s commitment.
“L’ambiente lavorativo è tra i migliori che abbia mai visto, con colleghi che riescono ad alleggerire facilmente i momenti più difficili di una giornata lavorativa.”
“People are fantastic! They are colleagues to me in the office and friends outside!”
Da inizio gennaio, Luigi Cammi ha fatto il suo ingresso in Hyntelo con il ruolo di Chief Sales Officer, focalizzato nel settore Pharma & Life Science.
For the third year in a row, Hyntelo has been classified in the “Leader Della Crescita” ranking, the survey conducted by Statista in partnership with IlSole24Ore. We...
The 2022 Gartner® Hype Cycle™ for Life Science Commercial Operations¹ “provides CIOs with strategy input by tracking maturity levels and adoption rates of key technologies to guide their strategic commercialization planning and investments.”
Dal 1 luglio, Giorgio Pinci supporta Hyntelo come Business Development Advisor. La sua esperienza poliedrica e la sua profonda conoscenza del settore pharma lo rende un partner ideale nell’affiancamento del team del prodotto Lyriko.
In today’s Pharma and Life Sciences landscape, engaging healthcare professionals (HCPs) effectively is more challenging—and more critical—than ever. That’s where Next Best Action (NBA) comes in.
Hyntelo (ex Sixth Sense) is proud to announce that it has been ranked among the 1.000 Europe’s fastest-growing companies in 2022 by Financial Times and Statista, for the second year in a row.
